BD has partnered with Techcyte to offer an artificial intelligence (AI)-enabled cervical cancer screening system, the companies announced Tuesday. Techcyte has developed a system to reduce the amount ...
(RTTNews) - Medical technology company Becton, Dickinson and Co. or BD (BDX) announced Wednesday that it has submitted a pre-market approval (PMA) supplement to the U.S. Food and Drug Administration ...
BD Life Sciences-Diagnostic Systems, a segment of BD (Becton, Dickinson and Company), a leading global medical technology company, announced the launch of BD SurePath Direct to Slide. It is a liquid ...
FRANKLIN LAKES, N.J., Feb. 21, 2023 /PRNewswire/ -- BD (Becton, Dickinson and Company (BDX)), a leading global medical technology company, today announced U.S. Food and Drug Administration (FDA) ...
Labs have been using test kit that is approved for Pap test%2C but not HPV testing FDA issued warning June 8 that using SurePath can produce false negative results Many gynecologists unaware of ...
In a significant move to enhance cervical cancer screening accuracy and accessibility in India, Indira IVF collaborates with BD SurePath. This partnership is aimed at helping improve patient care in ...
Becton, Dickinson or BD (BDX +2.0%) has submitted a pre-market approval (PMA) supplement to FDA for the use of the ThinPrep Pap Test PreservCyt Solution vial as an approved sample type for its ...
Becton, Dickinson and Company (BD) announced that it has submitted a pre-market approval (PMA) application to the U.S. Food and Drug Administration (FDA) for the BD Onclarity™ HPV Assay, its human ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback